Papillomavirus humain

Thèmes

HPV introduction - technical resources

Organisé par: Paul Bloem

View all Hot Topics

Du Centre de connaissances

Cost and operational context of HPV vaccine delivery in six countries

Auteur: PATH

Evaluating the costs and context of ongoing HPV vaccination programs

Auteur: PATH

Cost and operational context for national human papillomavirus (HPV) vaccine delivery in six low- and middle-income countries

Auteur: Mercy Mvundura, Rose Slavkovsky, Frédéric Debellut, Teddy Naddumba, Amare Bayeh, Cathy Ndiaye, Jacqueline Anena, Elisabeth Vodicka, Abdou Diop, Deepa Gamage, Clarisse Musanabaganwa, Ganesh Tatkan, Alfred Driwale, Meseret Zelalem, Ousseynou Badiane, Samitha Ginige, Ertenisa Hamilton, Hassan Sibomana, Yohannes Lakew, Francois Uwinkindi, Adugna Dhufera, Immaculate Ampeire, Sandeep Kumar, D. Scott LaMontagne

Controlled temperature chain (CTC) - New opportunities and reducing risk - TechNet Conference 2023

Auteur: Joanie Robertson, Anna-Lea Kahn, Sharvani Saraf

HPV vaccine implementation and revitalisation - TechNet Conference 2023

Auteur: Svetlana Stefanet, Joanie Robertson, Oya Zeren Afsar, Angela Capcelea, Daniel Salas

HPV Vaccine Cost Calculator

Auteur: PATH

VIEW-hub data on HPV introductions, coverage, and products

Auteur: International Vaccine Access Center (IVAC), Johns Hopkins University

UNICEF Pricing Information-HPV

Auteur: UNICEF

OPTIMIZAÇÃO DO ESQUEMA DE VACINAÇÃO ANTI-VPH Principais considerações para a tomada de decisões, a programação e a implementação

OPTIMIZACIÓN DEL ESQUEMA DE LA VACUNA CONTRA EL VPH Aspectos clave para la toma de decisiones, planificación e implementación

HPV VACCINE SCHEDULE OPTIMIZATION Key considerations for decision-making, planning, and implementation

Auteur: PATH, JSI, UNICEF, Gavi, the Vaccine Alliance, World Health Organization (WHO)

OPTIMISATION DU SCHÉMA DE VACCINATION ANTI-VPH Principales considérations en matière de prise de décision, de planification et de mise en œuvre

HPV VACCINE SCHEDULE OPTIMIZATION — KEY CONSIDERATIONS FOR DECISION-MAKING, PLANNING AND IMPLEMENTATION

ОПТИМИЗАЦИЯ СХЕМЫ ИММУНИЗАЦИИ ПРОТИВ ВПЧ - ОСНОВНЫЕ МОМЕНТЫ, НА КОТОРЫЕ НЕОБХОДИМО ОБРАТИТЬ ВНИМАНИЕ ПРИ ПРИНЯТИИ РЕШЕНИЙ, ПЛАНИРОВАНИИ И

P7 Optimizing vaccine regimens

Auteur: Andrew Pollard, Kristen Earle

Evidence of reduction in HPV infection and CIN2+ after vaccine introduction in Scotland

Auteur: R. L. Cameron, Kevin G. Pollock

User manual for WHO cervical cancer prevention and control costing tool: HPV vaccination module (‎C4P-HPV tool)‎

Auteur: World Health Organization (WHO)

W8-2 Changing the HPV Landscape with Indigenous Vaccine: CERVAVAC

Auteur: Hitt Sharma

W6-4 Reaching adolescent girls with the HPV vaccine

Auteur: Cathy Ndiaye

A quality improvement initiative to increase HPV vaccine rates using an educational and reminder strategy with parents of preteen girls

Auteur: Elizabeth A. Schlenk, Denise Charron-Prochownik, Betty Braxter, Brenda Cassidy

HPV Information Centre

Auteur: HPV Information Centre

Options for linking health interventions for adolescents with HPV vaccination

Auteur: World Health Organization (WHO)

Lier les interventions sanitaires à l’intention des adolescents avec la vaccination anti-PVH : différentes options

Auteur: Organisation Mondiale de la Santé (OMS)

Évaluation des données existantes sur la vaccination anti-HPV à dose unique

Auteur: Single dose HPV vaccine Consortium

Review of Existing Evidence on Single-Dose HPV Vaccination

Auteur: Single dose consortium

Impact of the COVID-19 Pandemic on Human Papillomavirus Vaccination in Brazil

Auteur: Ana Paula Sayuri Sato, Tércia Moreira Ribeiro Da Silva, Ana Carolina Micheletti Gomide Nogueira de Sá, Mery Natali Silva Abreu, Mark Anthony Beinner, Fernanda Penido Matozinhos, Ed Wilson Rodrigues Vieira

WHO position papers

Auteur: World Health Organization (WHO)

Communicating with caregivers about the Human Papillomavirus vaccination: facilitator’s guide

Auteur: World Health Organization (WHO)

Communicating with caregivers about the Human Papillomavirus vaccination: a tool to build confidence in communication skills among health workers

Auteur: World Health Organization (WHO)

Single Dose HPV vaccine Evidence master slides

Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India–2018–2019

Auteur: Danish Ahmed, Pradeep Haldar, Phumzay Denzongpa, Neelam Singh, Subhendu Roy, Nitasha Kaur, Pankaj Bhatnagar, Pauline Harvey, Kristin VanderEnde, Anagha Loharikar

Human papillomavirus vaccines: WHO position paper (‎2022 update)‎

Auteur: World Health Organization (WHO)

Vaccins contre les papillomavirus humains: note de synthèse de l’OMS (‎mise à jour de 2022)‎

Auteur: Organisation Mondiale de la Santé (OMS)

2021 WHO and UNICEF national estimates of immunization coverage (WUENIC)

Auteur: UNICEF, World Health Organization (WHO)

Human Papillomavirus Vaccination and Sexual Disinhibition in Females: A Systematic Review

Auteur: Soumyadeep Mukherjee, Tenesha Avent, Dudith Pierre-Victor, Rachel Clarke, Purnima Madhivanan, Naomie Jean-Baptiste, Brionna Powell, Prasad Bhoite, Karl Krupp

W5.3 Single-dose HPV Vaccination

Auteur: Aimee R. Kreimer

Improving HPV Vaccination Rates Using Maintenance-of-Certification Requirements.

Auteur: Stephanie L. Mayne, Xianqun Luan, Alexander G. Fiks

Parental attitudes towards male human papillomavirus vaccination: a pan-European cross-sectional survey

Auteur: Marjorie Adam, Laïla Idtaleb, Gitte Lee Mortensen

Maldives_Joint Covid-19 cPIE and HPV PIE

Auteur: Maldives Government

W6.2 Adolescent Immunization in Developing Countries: Obstacles and Opportunities

Auteur: Hartono Gunardi

COSTVAC tool

Auteur: Pan American Health Organization (PAHO)

Vaccine-Preventable Diseases (including pipeline vaccines)

Auteur: World Health Organization (WHO)

UNIVAC

Auteur: PAHO ProVac Initiative

Vaccine Impact Modelling Consortium (VIMC)

Auteur: Vaccine Impact Modelling Consortium

New single dose HPV vaccination evidence and resources

Auteur: Evan Simpson, Kiesha Prem, Anne Schuind

Synthèse technique des données actuelles publiées sur la vaccination à dose unique contre le PVH

Auteur: Single-Dose HPV Vaccine Evaluation Consortium

Résumé général des données actuelles publiées sur la vaccination à dose unique contre le PVH

Auteur: Single-Dose HPV Vaccine Evaluation Consortium

Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis

Auteur: Shelby Corman, Lixia Yao, Vincent Daniels, Linda Niccolai, Kunal Saxena, Craig Roberts, Smita Kothari

HPV Fact Sheet

Auteur: MoH Tanzania

HPV vaccine training video

Auteur: Immunization Academy

Banner

Auteur: MoH Senegal

Flyer

Auteur: MoH Senegal

Poster

Auteur: MoH Senegal

Communication Plan

Auteur: MoH Senegal

Tire Cover

Auteur: MoH Tanzania

HPV Vaccine Leaflet

Auteur: MoH Tanzania

HPV Vaccination Program Banner

Auteur: MoH Tanzania

HPV vaccine poster

Auteur: MoH Tanzania

Communications workplan and timeline

Auteur: MoH Tanzania

HPV Communications Strategy

Auteur: MoH Tanzania

HPV Key Messages

Auteur: MoH Zimbabwe

HPV FAQs

Auteur: MoH Zimbabwe

HPV Fact Sheet

Auteur: MoH Zimbabwe

Zimbabwe Communication Plan

Auteur: MoH Zimbabwe

HPV Vaccination Card Senegal

Auteur: MoH Senegal

HPV Vaccination Card Tanzania

Auteur: MoH Tanzania

Tanzania HPV vaccine community and school register

Auteur: MoH Tanzania

Tanzania HPV vaccine register

Auteur: MoH Tanzania

Routine Immunization Register

Auteur: MoH Tanzania

Daily HPV Summary Sheet

Auteur: MoH Zimbabwe

HPV Vaccination Tally Sheet

Auteur: MoH Zimbabwe

Tanzania HPV Vaccine Roll Out Plan

Auteur: MoH Tanzania

Tanzania HPV training agenda

Auteur: MoH Tanzania

Tanzania HPV microplanning tools

Auteur: MoH Tanzania

HPV Vaccine Introduction Training Slides

Auteur: MoH Tanzania

HPV Health Worker Training Agenda

Auteur: Ministry of Health Zimbabwe

Senegal Plan d’introduction du Vaccin contre le Virus du Papillome Humain

Auteur: MoH Senegal

Zimbabwe HPV Vaccine Introduction Readiness Assessment Questionnaires

Auteur: MoH Zimbabwe

HPV Flyer, Senegal

Auteur: MoH Senegal

Briefing on single-dose HPV vaccination evidence

Auteur: Anne Schuind, Evan Simpson, Kiesha Prem

A general summary of current published evidence for single-dose HPV vaccination

Auteur: Single-Dose HPV Vaccine Evaluation Consortium

Technical synthesis of the current published evidence for single-dose HPV vaccination

Auteur: Single-Dose HPV Vaccine Evaluation Consortium

Global Market Study: HPV - 2020

Auteur: World Health Organization (WHO)

Review of the current, public evidence on single-dose HPV vaccination

Auteur: Single-Dose HPV Vaccine Evaluation Consortium

Girl focus toolkit HPV campaign resource

Auteur: Girl Effect

Review of the current published evidence for single-dose HPV vaccination

Auteur: Single-Dose HPV Vaccine Evaluation Consortium

Rapid response to HPV vaccination crisis in Ireland

Auteur: Brenda Corcoran, Anna Clarke, Tom Barrett

Guide du vaccinateur VPH

School health screening and Immunization consent form

Auteur: MoE/MoH

Guia Informativo: vacinaçao contra o HPV

Auteur: MoH Brazil

Vaccine Pricing: Gavi Fully Self Financing and Accelerated Transition Countries

Auteur: World Health Organization (WHO)

Global Market Study: HPV - 2018

Auteur: World Health Organization (WHO)

HPV Vaccine Introduction Clearing House

Auteur: World Health Organization (WHO)

Scaling-up HPV vaccine introduction

Auteur: World Health Organization (WHO)

PRIME cost effectiveness tool

Auteur: World Health Organization (WHO)

HPV Introduction Guide (MWONGOZO WA MCHANJAJI)

Auteur: MoH Tanzania

HPV vaccine introduction guide

Auteur: MoH Tanzania

Rapport Mensuel PEV avec HPV

Auteur: MoH Senegal

Pre Post Test Formation HPV

Auteur: MoH Senegal

Registre HPV Senegal

Auteur: MoH Senegal

Feuille de Pointage HPV

Auteur: MoH Senegal

Guide Formation vaccin HPV

Auteur: MoH Senegal

Fiche Cancer HPV Enseignant

Auteur: MoH Senegal

HPV Guide Enseignant

Auteur: MoH Senegal

Fiche de synthese Mensuelle Vaccination HPV Ecole

Auteur: MoH Senegal

HPV vaccination Card Mozambique

Auteur: MoH Mozambique

Consent form

Auteur: MoH seychelles

Manual del vacunador

Auteur: MoH Argentina

Zimbabwe age calculator table tool

Auteur: Ministry of Health Zimbabwe

Zimbabwe Provincial Macroplanning Tool for HPV

Auteur: MoH Zimbabwe

Zimbabwe District Microplanning Tool for HPV

Auteur: MoH Zimbabwe

District level HPV summary form, Zimbabwe

Auteur: MoH Zimbabwe

HPV Register, Zimbabwe

Auteur: MoH Zimbabwe

HPV vaccination leaflet. Sir Lanka

Auteur: Ministry of Health, Sri Lanka

HPV Monitoring forms

Auteur: MoH South Africa

HPV vaccination training Facilitators guide, Ethiopia

Auteur: Ministry of health FDR Ethiopia

Bolivia HPV technical guidelines (lineamientos)

Auteur: Ministry of Health Bolivia

Cancer-salient messaging for Human Papillomavirus vaccine uptake: A randomized controlled trial

Auteur: Rachael M.Porter et al.

Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action

Safety of vaccines that have been kept outside of recommended temperatures: Reports to the Vaccine Adverse Event Reporting System (VAERS), 2008-2012

Auteur: Hibbs BF et al.

HPV vaccination strategies targeting hard-to-reach populations: Out-of-school girls in LMICs

Auteur: Kimberly Bonner et al.

Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study

Auteur: Kimberley Kavanagh et al.

Untangling the psychosocial predictors of HPV vaccination decision-making among parents of boys

Auteur: Samara Perez et al.

Persuasive texts for prompting action: Agency assignment in HPV vaccination reminders

Auteur: Matthew S.McGlone et al.

Factors influencing the recommendation of the Human Papillomavirus vaccine by South African doctors working in a tertiary hospital

Auteur: Muhammad Ehsanul Hoque

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries

Auteur: Katherine E. Gallagher et al.

PDSA Cycle Focus: Provider Prompts

Auteur: American Academy of Pediatrics (AAP)

Human papillomavirus (HPV) vaccination and cervical cancer

Auteur: Public Health England

Successive introduction of four new vaccines in Rwanda: High coverage and rapid scale up of Rwanda´s expanded immunization program from 2009 to 2013

Auteur: Maurice Gatera et al.

Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China

Auteur: Yi-Jun Liu et al.

Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis

Auteur: Laia Bruni et al.

HPV vaccine lessons learnt project overview

Auteur: PATH

Comparative evaluation of the potential impact of rotavirus versus hpv vaccination in GAVI-eligible countries: A preliminary analysis focused on the relative disease burden

Auteur: Sun-Young Kim et al.

Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model

Auteur: Jorge Alberto Gomez et al.

Ethical considerations of universal vaccination against human papilloma virus

Auteur: Pedro Navarro-Illana et al.

Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Vietnam

Auteur: Levin CE et al.

Towards the eradication of HPV infection through universal specific vaccination

Auteur: Piergiorgio Crosignani et al.

Human Papillomavirus Vaccine - Knowledge and Attitudes among Parents of Children Aged 10-14 Years: a Cross-sectional Study, Tîrgu Mureş, Romania.

Auteur: Septimiu Voidăzan, Minodora Dobreanu, Adelina Grigore, Silviu-Horia Morariu, Monica Tarcea

Adverse events following school-based vaccination of girls with quadrivalent human papillomavirus vaccine in Slovenia, 2009 to 2013

Auteur: M Šubelj et al.

Current global pricing for human papillomavirus vaccines brings the greatest economic benefits to rich countries

Auteur: Niamh Herlihy et al.

HPV vaccination programme in Japan

Auteur: Stuart Gilmour et al.

Motivation for HPV Vaccination Among Young Adult Men: Validation of TTM Decisional Balance and Self-Efficacy Constructs.

Auteur: Andrea L. Paiva, Nicole R. Amoyal, Anne C. Fernandez, James O. Prochaska

Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: a systematic review.

Auteur: Esther L. Moss, Susan M. Sherman, Yadava B. Jeve, Hersha Patel

Effects of Consideration of Future Consequences and Temporal Framing on Acceptance of the HPV Vaccine Among Young Adults. - PubMed - NCBI

Auteur: Jarim Kim, Xiaoli Nan

Near real-time vaccine safety surveillance using electronic health records-a systematic review of the application of statistical methods.

Auteur: Sara L. Thomas, Nick J. Andrews, Andreia Leite

A randomized intervention study to evaluate whether electronic messaging can increase HPV vaccine completion and knowledge among college students.

Auteur: Alice R Richman, Ellen J Goldberg, Essie Torres, LaDonna Maddy

Tanzania: costing nationwide HPV vaccine delivery using the WHO cervical cancer prevention tool

Auteur: Raymond Hutubessy et al.

Cross-protective efficacy of two human papillomavirus vaccines: systematic review and meta-analysis

Auteur: Talía Malagón et al.

The Vaccination Confidence Scale: A brief measure of parents’ vaccination beliefs

Auteur: Melissa B. Gilkey et al.

Geographic factors and Human Papillomavirus (HPV) vaccination initiation among adolescent girls in the United States

Auteur: Kevin A. Henry et al.

Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012

Auteur: M. Saraiya, J. Rodriguez, M. Malone, Z. Berkowitz

Commercially available molecular tests for human papillomaviruses (HPV): 2015 update

Auteur: Katja Seme, Anja Oštrbenk, Boštjan J. Kocjan, Mario Poljak

Parental Attitudes and Beliefs Regarding the Nine-Valent Human Papillomavirus Vaccine.

Auteur: Holly B. Fontenot, Gregory D. Zimet, Vanessa Domush

Human Papillomavirus Infection and Vaccination.

Factors Related to Human Papillomavirus (HPV) Vaccination in College Men.

Auteur: Ratanasiripong, Nop Thodsama

Message Framing, Perceived Susceptibility, and Intentions to Vaccinate Children Against HPV Among African American Parents.

Auteur: Xiaoli Nan, Kate Tracy, Min Qi Wang, Cheryl Holt, Adam Richards, Kelly Madden

Association of Older Sister's HPV Vaccination Status on HPV Vaccine Receipt by Adolescents.

Auteur: Sarah J Clark, Shannon Stokley, Allison M Fisher, Stephanie L Filipp, Anne E Cowan

Search Engine Ranking, Quality, and Content of Web Pages That Are Critical Versus Noncritical of Human Papillomavirus Vaccine.

Auteur: Linda Y. Fu, Jill G. Joseph, Pamela Hu, Zachary Spoehr-Labutta, Kathleen Zook

Intellectual property rights and challenges for development of affordable human papillomavirus, rotavirus and pneumococcal vaccines: Patent landscaping and perspectives of developing country vaccine manufacturers

Auteur: Subhashini Chandrasekharan et al.

Is routine human papillomavirus vaccination an option for Ghana?

Auteur: Ama K. Edwin

Achieving high uptake of human papillomavirus vaccine in Cameroon: Lessons learned in overcoming challenges

Auteur: Javier Gordon Ogembo et al.

Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014 — United States

Auteur: Shannon Stokley et al.

Can HPV vaccine have other health benefits more than cancer prevention? A systematic review of association between cervical HPV infection and preterm birth

Auteur: Qi-tao Huang, Mei Zhong et al.

Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study

Auteur: Sepehr N Tabrizi et al.

Do cervical cancer data justify HPV vaccination in India?

Auteur: I Mattheij et al.

What is the responsibility of national government with respect to vaccination?

Auteur: Marcel F. Verweij et al.

Effect of decision support on missed opportunities for Human Papillomavirus Vaccination

Auteur: Mayne SL et al.

Safety of quadrivalent human papillomavirus vaccine (Gardasil®) in pregnancy: Adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006–2013

Auteur: Pedro L. Moro et al.

Reported adverse events in young women following quadrivalent human papillomavirus vaccination

Auteur: Naleway Al et al.

Auteur: Karen Canfell et al.

New HPV vaccine provides wider protection

Auteur: Anita Slomski

Immunogenicity and safety of the human papillomavirus vaccine in patients with autoimmune diseases: A systematic review

Auteur: Paolo Pellegrino et al.

Quadrivalent Human Papillomavirus Vaccine Initiation in Boys Before and Since Routine Use: Southern California, 2009-2013

Auteur: Steven J Jacobsen, Lina S Sy, Chun R. Chao, Nilesh J. Patel, Margo A. Sidell, Bradley K Ackerson, Hung Fu Tseng, Rulin C. Hechter, Jeff M. Slezak

Predictors of Human Papillomavirus Vaccine Completion Among Female and Male Vaccine Initiators in Family Planning Centers

Auteur: Julia E. Kohn, Priscilla M. Lopez, Zoe D. Unger, Hannah R. Simons

Human Papillomavirus Vaccine Uptake After a Tailored, Online Educational Intervention for Female University Students: A Randomized Controlled Trial

Auteur: Sarah M. Pennewell, Melissa K. Zochowski, Ruth C. Carlos, Divya A. Patel, Vanessa K. Dalton, Alaina T. Bennett, Alice M. Chi

Introduction of a National HPV vaccination program into Bhutan

Auteur: Tandin Dorji et al.

Civil society: A critical new advocate for vaccination in Europe

Auteur: Vanina Laurent-Ledru et al.

Human papillomavirus vaccine and men: what are the obstacles and challenges?

Auteur: Stupiansky NW et al.

Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda

Auteur: African Health Sciences